Topical Microbial Therapeutics against Respiratory Viral Infections

This publication has 103 references indexed in Scilit:

• Nasally administered Lactobacillus rhamnosus strains differentially modulate respiratory antiviral immune responses and induce protection against respiratory syncytial virus infection
  BMC Immunology, 2013
• Effect of intranasal administration of Lactobacillus pentosus S-PT84 on influenza virus infection in mice
  International Immunopharmacology, 2010
• Intranasal administration of Lactobacillus rhamnosus GG protects mice from H1N1 influenza virus infection by regulating respiratory immune responses
  Letters in Applied Microbiology, 2010
• Broad-SpectrumIn VitroActivity andIn VivoEfficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the FamilyCoronaviridae
  Journal of Virology, 2010
• Activation of innate immune antiviral responses by Nod2
  Nature Immunology, 2009
• The NLRP3 Inflammasome Mediates In Vivo Innate Immunity to Influenza A Virus through Recognition of Viral RNA
  Immunity, 2009
• Augmented Lung Inflammation Protects against Influenza A Pneumonia
  PLOS ONE, 2009
• Sustained desensitization to bacterial Toll-like receptor ligands after resolutionof respiratory influenza infection
  Journal of Experimental Medicine, 2008
• RIG-I-Mediated Antiviral Responses to Single-Stranded RNA Bearing 5'-Phosphates
  Science, 2006
• Mucosal Immunization with Surface-Displayed Severe Acute Respiratory Syndrome Coronavirus Spike Protein onLactobacillus caseiInduces Neutralizing Antibodies in Mice
  Journal of Virology, 2006